ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BioMarin Receives FDA Fast Track Designation for PKU Investigational Gene Therapy
October 12, 2020BioMarin Pharmaceutical announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BMN 307, an investigational gene therapy for the treatment of individuals with PKU. -
BioMarin to Begin Clinical Trial with BMN 307 Gene Therapy
January 17, 2020BioMarin announced both the U.S. Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. have granted the Company Investigational New Drug (IND) status and approved its Clinical Trial Application (
Pharma Sources Insight January 2025
